1) In regards to DTC eligibility, what does it mean for the stock and company?
2) How are things progressing with Kaitests.com and what does the go live with e-commerce look like?
3) Could you update on the progression of telemedicine platform, growth in patient use of it, and how well the MedX trial, if it has begun, is integrating into the daily clinic operations.